SNSW(SH:688117)2024-08-02 09:14Company Overview - Chengdu Saintno Biological Technology Co., Ltd. was established in July 2001 and is recognized as a high-tech enterprise in Sichuan Province [2] - The company primarily provides CDMO services for peptide drugs, establishing a comprehensive R&D pipeline and industry platform [2] - It has completed over 40 CDMO projects for new drug development, with 2 products approved for commercialization, 1 in the production application stage, and 20 in clinical trial stages [2][3] Financial Performance - In the first half of 2024, the company achieved revenue of CNY 198.94 million, a year-on-year increase of 14.44% [2] - The net profit attributable to shareholders was CNY 21.79 million, up 8.14% year-on-year [2] - The net profit after deducting non-recurring gains and losses was CNY 19.12 million, reflecting a significant increase of 106.55% [2] R&D and Product Development - The company is advancing multiple GLP-1 innovative drug projects, with one product already submitted for production and others in various clinical trial phases [2][3] - The company has a complete R&D pipeline for peptide APIs and formulations, enhancing its market share and service capabilities [3] Capacity Expansion and Market Strategy - The company has completed the construction of several production lines, including a project with an annual capacity of 395 kg of peptide APIs, which is expected to enter trial production soon [3] - Plans for international market expansion include establishing a marketing system and exploring new markets in regions such as the US, EU, and Southeast Asia [3] Sales Strategy - The sales strategy involves a dual approach of seeking agents while building an internal team to enhance market coverage and sales growth [4] - The company aims to improve its market competitiveness through professional sales and marketing personnel [4] Risk Warning - The content related to industry forecasts and company development strategies should not be considered as commitments or guarantees from the company or its management [4]